RapidAI
UnclaimedClinical AI platform enhancing assessment and transforming care in healthcare.
Visit WebsitePaidVisit Website
TL;DR - RapidAI
- Provides AI-driven clinical decision support for various medical conditions.
- Enhances patient outcomes, operational efficiency, and financial viability for healthcare providers.
- Offers real-time insights, automated measurements, and collaborative tools for medical teams.
Pricing: Paid only
Best for: Enterprises & pros
Pros & Cons
Pros
- Extensive clinical validation with numerous publications and FDA clearances
- Enhances diagnostic confidence and streamlines workflows
- Improves patient outcomes through faster, more confident decision-making
- Facilitates real-time collaboration among medical teams
- Provides detailed analytics for performance monitoring
Cons
- No publicly available pricing information
- Requires integration into existing healthcare ecosystems
Key Features
Deep clinical decision-making support for various disease statesReal-time collaboration and alerts via mobile appImaging prioritization and AI decision support for Radiology (Navigator Pro)Custom performance analytics platform (Rapid Insights)Third-party integration for interoperabilityRapid identification of suspected anomalies (Triage)Localization and visualization of regions of concernAutomated quantification of key metrics (e.g., blood flow, anomaly growth)
Pricing
Paid
RapidAI offers paid plans. Visit their website for current pricing details.
About RapidAI
By Toolradar Team·
RapidAI is a clinical AI platform designed to enhance medical assessment and transform patient care across various disease states. It leverages deep clinical AI to provide decision support for healthcare professionals, aiming to improve patient outcomes, drive operational efficiency, and strengthen financial viability for healthcare providers.
The platform offers cutting-edge solutions for neurovascular conditions (stroke, trauma, aneurysm), cardiac & vascular issues (pulmonary embolism, aortic disease), and radiology workflows. It provides real-time insights, automates key metrics, and facilitates cross-disciplinary collaboration through its enterprise platform and mobile app. RapidAI is built on extensive clinical validation, with numerous publications and trials supporting its efficacy.
Reviews
No reviews yet. Be the first to review RapidAI!
Best RapidAI Alternatives
Top alternatives based on features, pricing, and user needs.
Explore More
RapidAI FAQ
How does RapidAI's platform support clinical decision-making across different medical specialties?
The Rapid Enterprise™ Platform facilitates the cross-disciplinary deployment of deep clinical AI, offering decision support to various healthcare professionals. It provides specialized solutions for neurovascular, cardiac & vascular, and radiology, enhancing assessment and transforming care in these areas.
What specific functionalities does the Rapid mobile app offer for urgent cases?
The Rapid mobile app provides real-time collaboration and alerts for urgent cases. Users can receive notifications of suspected cases, review AI outputs and source imaging in a DICOM viewer, and coordinate across teams and sites with in-app messaging.
Beyond anomaly detection, what advanced capabilities does RapidAI's Deep Clinical AI offer?
RapidAI's Deep Clinical AI goes beyond anomaly detection to include localization of regions of concern, quantification of key metrics like blood flow and anomaly growth, and characterization of anomaly severity and morphology. It also provides automated 3D renderings and AI outputs for visualization, and longitudinal tracking to monitor changes over time.
How does Rapid Aortic specifically aid in the management and surveillance of aortic patients?
Rapid Aortic automatically analyzes all C/A/P CT scans with an aorta to identify aortic disease, including non-contrast and post-treatment scans. It generates automated measurements, including six zonal maximums and 18 landmark measurements, and allows for side-by-side comparison of current and prior scans to track changes over time.
What evidence supports the clinical rigor and validation of RapidAI's platform?
The platform is backed by extensive clinical rigor, with over 700 publications, 25+ clinical trials, and 11 publications in the New England Journal of Medicine. This demonstrates a strong foundation of clinical validation and disease state expertise.
Source: rapidai.com